These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28707787)

  • 21. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.
    Brandimarte G; Tursi A
    Med Sci Monit; 2004 May; 10(5):PI70-3. PubMed ID: 15114281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis.
    Urushidani S; Kuriyama A; Matsumura M
    J Gastroenterol Hepatol; 2018 Jan; 33(1):12-19. PubMed ID: 28623877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Authors' reply: Outcomes after nonoperative diverticulitis management: Longitudinal risk for survivors.
    Ho VP; Nash GM; Lee SW
    J Trauma Acute Care Surg; 2020 Aug; 89(2):e19-e20. PubMed ID: 32301882
    [No Abstract]   [Full Text] [Related]  

  • 24. Colonic diverticular disease. Treatment and prevention.
    Gargallo Puyuelo CJ; Sopeña F; Lanas Arbeloa A
    Gastroenterol Hepatol; 2015 Dec; 38(10):590-9. PubMed ID: 25979437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
    Strate LL; Modi R; Cohen E; Spiegel BM
    Am J Gastroenterol; 2012 Oct; 107(10):1486-93. PubMed ID: 22777341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diverticulitis : Domain of conservative or drug therapy?].
    Böhm S; Kruis W
    Internist (Berl); 2017 Jul; 58(7):745-752. PubMed ID: 28608124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diverticulitis: new insights on the traditional point of view.
    Moubax K; Urbain D
    Acta Gastroenterol Belg; 2015; 78(1):38-48. PubMed ID: 26118576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical inquiries: How can you help prevent a recurrence of diverticulitis?
    Weisberger L; Jamieson B
    J Fam Pract; 2009 Jul; 58(7):381-2. PubMed ID: 19607778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.
    Comparato G; Fanigliulo L; Cavallaro LG; Aragona G; Cavestro GM; Iori V; Maino M; Mazzocchi G; Muzzetto P; Colla G; Sianesi M; Franzé A; Mario FD
    Dig Dis Sci; 2007 Nov; 52(11):2934-41. PubMed ID: 17410435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Authors reply: Damage control surgery in patients with generalized peritonitis secondary to perforated diverticulitis-the risk of overtreatment.
    Sohn M; Iesalnieks I
    Tech Coloproctol; 2018 Jul; 22(7):565-566. PubMed ID: 29980887
    [No Abstract]   [Full Text] [Related]  

  • 31. Balsalazide plus high-potency probiotic preparation (VSL[sharp]3) in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon.
    Tursi A
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S119-22. PubMed ID: 18806701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent diverticulitis.
    Comparato G; Di Mario F;
    J Clin Gastroenterol; 2008; 42(10):1130-4. PubMed ID: 18936650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A hypothesis: is diverticulitis a type of inflammatory bowel disease?
    Floch MH
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S121-5. PubMed ID: 16885694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of colon cancer among patients diagnosed with left colonic or sigmoid acute diverticulitis is higher than in the general population.
    Meyer J; Thomopoulos T; Usel M; Gjika E; Bouchardy C; Morel P; Ris F
    Surg Endosc; 2015 Nov; 29(11):3331-7. PubMed ID: 25631117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing diverticulitis: mesalamine may still be indicated in the decision.
    Floch MH
    Gastroenterology; 2015 Apr; 148(4):856. PubMed ID: 25726738
    [No Abstract]   [Full Text] [Related]  

  • 36. New trends in the management of diverticulitis and colonic diverticular disease.
    Medina-Fernández FJ; Díaz-Jiménez N; Gallardo-Herrera AB; Gómez-Luque I; Garcilazo-Arsimendi DJ; Gómez-Barbadillo J
    Rev Esp Enferm Dig; 2015 Mar; 107(3):162-70. PubMed ID: 25733040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Recurrent Disease and Surgery Following an Admission for Acute Diverticulitis.
    El-Sayed C; Radley S; Mytton J; Evison F; Ward ST
    Dis Colon Rectum; 2018 Mar; 61(3):382-389. PubMed ID: 29420430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of 5-ASA in the treatment of colonic diverticular disease.
    Gatta L; Vakil N; Vaira D; Pilotto A; Curlo M; Comparato G; Leandro G; Ferro U; Lera M; Milletti S; Di Mario F
    J Clin Gastroenterol; 2010 Feb; 44(2):113-9. PubMed ID: 19561530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conservative treatment for patients with acute right colonic diverticulitis.
    Moon HJ; Park JK; Lee JI; Lee JH; Shin HJ; Kim WS; Kim MS; Jeong JH
    Am Surg; 2007 Dec; 73(12):1237-41. PubMed ID: 18186379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.
    Festi D; Colecchia A
    Am J Gastroenterol; 2009 Feb; 104(2):532. PubMed ID: 19174809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.